Category: Clinical Trial

Focused ultrasound temporarily opens the blood-brain barrier to allow the delivery of more cancer-fighting agent to the tumor.

View a list of trials now enrolling at UVA Heart & Vascular Center.

Learn more about the SALT Study and a trial focusing on developing a sentinel lymph node mapping (SLNm) technique for patients with early-stage rectal cancer.

An expert in immunotherapy, Lawrence G. Lum, MD, DSc joins UVA Cancer Center as the scientific director of bone marrow transplantation. One of Lum’s priorities is pioneering a new method of activating the body’s own T cells to target tumor cells.

High-grade glioma patients at UVA now have the opportunity to participate in Toca 5, an international clinical trial of a new, virus-based procedure that activates therapeutics selectively within the brain tumor, leading to fewer side effects.

Precision Breast IORT is a unique form of IORT developed at UVA — now being examined in a Phase II clinical trial — that incorporates CT imaging and high-dose rate (HDR) brachytherapy.

Find out if your patients are eligible for the next-generation LVAD treatment or novel stem cell therapy, now being examined by leading heart specialists at UVA.

Mark B. Williams, PhD, has devoted the past decade to developing a new scanner that he hopes will give women and their physicians better diagnostic information.

Neurologist Andrew Southerland, MD, is spearheading a study to test the feasibility of mobile neurological assessments during ambulance transport for stroke victims.

A new application of non-invasive focused ultrasound technology is being explored at UVA with the launch of a study for benign tumors of the breast.